AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Macglim M 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Shamac Health Care Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Macglim M 2mg/500mg Tablet SR

Diabetic patients with type 2 mellitus may benefit from Glycemia-M 2mg/500mg extended-release tablets, a dual-action antidiabetic medication. This formulation manages blood glucose levels in adults by combining two therapeutic agents. Administer Glycemia-M with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood glucose monitoring. Continued use, even with controlled blood sugar, is crucial. Abrupt cessation without medical consultation risks elevated blood glucose, potentially leading to complications including kidney impairment, visual disturbances, neuropathy, and limb loss. Remember, Glycemia-M is part of a comprehensive diabetes management plan that includes dietary adjustments, exercise, and weight management as directed by your doctor. Lifestyle modifications are essential for diabetes control. Hypoglycemia (low blood sugar) is a common adverse effect, presenting as sweating, dizziness, headache, or tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are necessary. Alcohol consumption should be limited due to its hypoglycemic potential. Other potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalgia, and upper respiratory infections. Weight gain may occur. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal dysfunction. Prior heart conditions should be disclosed to your physician before commencing treatment. Consult your doctor before use during pregnancy or lactation. Regular blood glucose checks, along with periodic blood tests to evaluate blood cell counts and liver function, are recommended.

Uses of Macglim M 2mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Macglim M 2mg/500mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Macglim M 2mg/500mg Sustained-Release Tablets should be administered with a meal.

Common Side effects of Macglim M 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Macglim M 2mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Macglim M 2mg/500mg Tablet SR whole; do not fracture, pulverize, or chew it. Administer this extended-release tablet with a meal.

How Macglim M 2mg/500mg Tablet SR works:

Macglim M SR tablets (2mg/500mg) combine glimepiride and metformin, two agents that manage blood sugar. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood glucose levels. Metformin, a biguanide, acts through multiple mechanisms: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol consumption and Macglim M 2mg/500mg Tablet SR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Macglim M tablets (2mg/500mg) may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Prolonged-release Macglim M 2mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Impaired driving may result from excessively high or low blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Exercise caution when administering Macglim M 2mg/500mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. For patients exhibiting severe kidney disease, Macglim M 2mg/500mg SR tablets are contraindicated. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Macglim M 2mg/500mg SR tablets cautiously, potentially requiring dosage modifications. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; however, it's contraindicated in patients with severe liver dysfunction.

What if you forget to take Macglim M 2mg/500mg Tablet SR :

Should you forget to take a Macglim M 2mg/500mg SR tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Macglim M 2mg/500mg Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Macglim M 2mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Macglim M 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). While rare, this harmful side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Macglim M 2mg/500mg Tablet SR and seek immediate medical attention.
Macglim M 2mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Macglim M is not suitable for type 1 DM.
Macglim M 2mg/500mg SR tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Macglim M 2mg/500mg Tablet SR can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Macglim M 2mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concomitant antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Consuming alcohol with Macglim M 2mg/500mg Tablet SR is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Macglim M 2mg/500mg Table...
85
MRP 99
13% off